Hydroxyapatite Market

Global Hydroxyapatite Market Size (2024 to 2029)

The size of the global Hydroxyapatite market is estimated to reach USD 3.38 billion by 2029 from USD 2.6 billion in 2024, growing at a CAGR of 5.4% from 2024 to 2029.

MARKET OVERVIEW

Hydroxyapatite, the mineral form of calcium apatite, consists of a phosphate and a hydroxyl group. It is an important component of teeth that provides high stiffness and better enamel remineralization than saliva. Hydroxyapatite coatings in orthopedic implants and dental care products offer improved properties, including increased bone-to-hydroxyapatite healing, faster bone healing at the bone-implant interface, and corrosion inhibition. Manufacturers are replacing conventional titanium plasma coatings with nanohydroxyapatite coatings. It is a calcium phosphate similar to hard human tissue in its morphology and composition. Hydroxyapatite has been widely used in clinical bone applications. A significant property of hydroxyapatite is its stability in comparison to other calcium phosphates. The escalating interest in hydroxyapatite is owing to its chemical composition which is the same as that of the inorganic component of natural bone. Hydroxyapatite is commercially available either from a natural source or as a synthetic hydroxyapatite. The important treatment parameters of hydroxyapatite are sintering temperature, stoichiometry, phase purity, particle size of the particles, and porosity.

MARKET DRIVERS AND RESTRAINTS

The global hydroxyapatite market is expected to grow at a rapid rate throughout the foreseen period owing to escalated customer awareness of bioactive ceramics and escalating healthcare expenses worldwide. Hydroxyapatite (HA) is an important component of normal bones and teeth that is already used as a coating in orthopedic implants to promote bone fixation and expansion. The escalating call for dental and orthopedic implants, together with the escalating popularity of bioactive materials and solid investments in R&D activities to expand hydroxyapatite applications, should stimulate the expansion of the global HAp market over the outlook period.

Hydroxyapatite is an osteoconductive and biocompatible material that is added to the fundamental segment of bone. Silver-coated or silver-containing HAp integration strategies incorporate the sol-gel technique, the wet synthesis strategy, particle trading, and hot spatter. To maintain the antibacterial movement of the material in vivo, silver must remain in an ionic state and be firmly adhered to the coated surface. A new safe hydroxyapatite film for a microscopic organism in which ionic silver is constructed to immobilize these organisms using inositol hexaphosphate chelation via a low heat flood process. The safe coating of this microorganism has shown tremendous antibacterial movement in vitro and in vivo. Hydroxyapatite is used as a characteristic bone substitute in orthopedic applications. It is also generally used to coat metal inserts in order to enhance their biocompatibility. The maturation of the population and the development of the availability and reasonableness of orthopedic drugs stimulate the development of orthopedic applications that are part of the hydroxyapatite market.

The escalating consumption of hydroxyapatite, due to the increase in research and development activities aimed at escalating the applicability of hydroxyapatite in the medical sector, is a crucial factor in the expansion of the global hydroxyapatite market. Also, the increase in the consumption of hydroxyapatite worldwide, due to the escalating call for dental implants, is another factor that should stimulate expansion in the target market during the forecast period. Moreover, the surge in developments in the healthcare sector and easy access to raw materials are other factors that are foreseen to promote the expansion of the global hydroxyapatite market in the future.

However, the low mechanical resistance of hydroxyapatite is an essential factor that is supposed to limit the expansion of the global hydroxyapatite market during the conjecture period.

REPORT COVERAGE

DETAILED SEGMENTATION OF THE GLOBAL HYDROXYAPATITE MARKET INCLUDED IN THIS REPORT

This research report on the global hydroxyapatite market has been segmented and sub-segmented based on type, application, and region.

Global Hydroxyapatite Market By Type

• Nano-size
• Micro-size
• Greater than Micrometers

The nano-size sector is known to hold a substantial share of the global Hydroxyapatite industry in the year 2020.

Global Hydroxyapatite Market By Application

• Orthopedic
• Dental Care
• Plastic Surgery
• Others

The orthopedic sector is dominating the Hydroxyapatite industry in 2021 and is predicted to dominate the industry throughout the foreseen period also.

REGIONAL ANALYSIS

• North America
• Europe 
• Asia Pacific
• Latin America 
• Middle East & Africa 

The North American region accounted for the majority of the global hydroxyapatite market in 2023.

It is also expected to experience significant expansion in the market during the conjecture period. The hydroxyapatite market in the Asia-Pacific is expected to grow at the highest CAGR over the outlook period. The increased call for hydroxyapatite in Asian countries is stimulating the expansion of the hydroxyapatite market in this area. Moreover, an aging population, escalating disposable incomes, and escalating combined awareness of the advantages of dental bone grafting over conventional treatments provide a huge opportunity for expansion for hydroxyapatite makers in the region of Asia-Pacific.

Currently, the North American market represents the largest market share in the world hydroxyapatite market in terms of income. This can be attributed to the presence of the main hydroxyapatite manufacturers in the region. The Asia Pacific market is also expected to experience significant expansion during the forecast period due to increased call for hydroxyapatite due to increased aging and population awareness.

KEY MARKET PLAYERS IN THE GLOBAL HYDROXYAPATITE MARKET

FLUIDINOVA (Portugal), SofSera Corporation (Japan), Berkeley Advanced Biomaterials (US), Taihei Chemical Industrial Co. Ltd. (Japan), SigmaGraft (US), CAM Bioceramics (Netherlands) are some of the notable companies in the global Hydroxyapatite market.

RECENT HAPPENINGS IN THE MARKET

• Prominence and Onkos Surgical partnered on hydroxyapatite surface technology in limb salvage surgery. Onkos Surgical Inclusive has declared that it has come into partnership with Promimic AB to commercialize Promimic's proprietary Hydroxyapatite (HA) Surface Technologies in Limb Salvage Surgery.
• Medtronic has declared the introduction of its KYPHON ActivOs 10 Bone Cement with Hydroxyapatite. Polymethylmethacrylate bone cement is for employment in the treatment of patients with vertebral compression fractures suffering very less invasive surgery with KYPHON Balloon Kyphoplasty.